Sabinsa Studies On Gugulipid®
1. Open Field Study to Evaluate
GugulipidÒ in the Treatment of Dyslipidemias - Department
of Veterans Affairs Medical Center (Arizona)
The purpose of this study is to investigate the effect of
GugulipidÒ on serum lipids (i.e. cholesterol, LDL,
HDL, triglycerides) in individuals with dyslipidemias. All individuals are volunteers who
have serum cholesterol levels > 200 mg/dL. Serum cholesterol levels and the levels of
other parameters are measured prior to and after treatment with GugulipidÒ.
2. IND Study #59, 172 - Randomized,
Double-Blind, Placebo-Controlled Trial Evaluating the Safety and Efficacy of
GugulipidÒ in Americans with Hypercholesterolemia -
University of Pennsylvania.
The purpose of this study is to
evaluate the efficacy and safety of GugulipidÒ in
Americans with dyslipidemias. The participants of the study are volunteers, 18 years and
older, who have LDL levels between 130-190 mg/dL and triglycerides less than 400 mg/dL.
The safety of the study will be measured by self-reported adverse events. In addition
hematological and blood biochemistry parameters will be assessed throughout the study to
monitor safety and efficacy. The efficacy of GugulipidÒ
will be measured as a percent change from baseline in total cholesterol, LDL, HDL, and
triglycerides in GugulipidÒ versus placebo groups.
statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, cure, or prevent any disease"
Copyright © Sabinsa Corporation. All Rights Reserved